Part 5/11:
In addition, a new drug combination trial has demonstrated potential to extend tumor growth inhibition significantly longer than standard treatments, which could represent a substantial step forward for lung cancer patients.
Prostate Cancer: Early Diagnosis via Innovative Testing
Prostate cancer remains the second most commonly diagnosed cancer among men, with around 1.5 million annual cases. Current risk factors and the slower growth rate of tumors contribute to favorable survival rates, especially for cases diagnosed in early stages.